Pediatrix Medical
MD
Pediatrix Medical (MD) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Jefferies | Downgraded | Buy → Hold | $28.00 from $27.00 | Aug 19, 2026 |
| UBS | Maintained | Neutral | $28.00 from $25.00 | Aug 6, 2026 |
| Truist Securities | Maintained | Hold | $28.00 from $23.00 | Jul 14, 2026 |
| UBS | Maintained | Neutral | $25.00 from $22.00 | May 12, 2026 |
| Truist Securities | Maintained | Hold | $23.00 from $21.00 | Apr 13, 2026 |
| UBS | Maintained | Neutral | $22.00 from $23.00 | Feb 24, 2026 |
| Truist Securities | Maintained | Hold | $21.00 from $24.00 | Feb 20, 2026 |
| Truist Securities | Maintained | Hold | $24.00 from $17.00 | Nov 10, 2025 |
| UBS | Maintained | Neutral | $23.00 from $16.50 | Nov 5, 2025 |
| Leerink Partners | Maintained | Market Perform | $17.00 from $14.50 | Sep 5, 2025 |
| UBS | Maintained | Neutral | $16.50 from $16.00 | Aug 14, 2025 |
| UBS | Maintained | Neutral | $16.00 from $18.50 | May 12, 2025 |
| Macquarie | Maintained | Outperform | $20.00 from $19.00 | May 8, 2025 |
| Truist Securities | Maintained | Hold | $16.00 from $18.00 | Apr 11, 2025 |
| Truist Securities | Maintained | Hold | $18.00 from $15.00 | Feb 21, 2025 |
| UBS | Maintained | Neutral | $18.50 from $16.50 | Feb 21, 2025 |
| Truist Securities | Maintained | Hold | $15.00 from $16.00 | Jan 6, 2025 |
| Macquarie | Initiated Coverage | Outperform | $18.00 | Dec 16, 2024 |
| Mizuho | Maintained | Neutral | $15.00 from $13.00 | Nov 19, 2024 |
| Jefferies | Maintained | Buy | $18.00 from $14.00 | Nov 5, 2024 |
Frequently asked questions
What is the latest analyst rating on MD?
On Aug 19, 2026, Jefferies downgraded Pediatrix Medical to Hold with a price target of $28.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.